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Abstract
Autochtonous toxigenic Corynebacterium diphtheriae have disappeared in mainland France, but non-toxigenic C. diphtheriae are still
circulating. Using phenotypic and molecular tools, we retrospectively characterized 103 non-toxigenic C. diphtheriae collected in mainland
France and highlight several changes. The proportion of C. diphtheriae belfanti increased between 1977 and 2011 and it is the most frequent
biotype recovered in recent years. Resistance to ciproﬂoxacin has increased and most isolates with decreased sensitivity belong to the
belfanti biotype. Using multilocus sequence typing, we demonstrate that French isolates are distributed in a large number of sequence types
and identify three distinct lineages. C. diphtheriae mitis and gravis form lineage I while C. diphtheriae belfanti forms lineages II and III. Almost
all isolates of lineage II are part of a unique clonal complex or are very close to it. Most French isolates have a dtxR sequence homologous to
that of toxigenic isolates, suggesting that if lyzogenised by a corynephage, they can express diphtheria toxin.
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Introduction
The introduction of vaccination with diphtheria toxoid in the
early 20th century changed diphtheria epidemiology substan-
tially. The disease has become rare in countries with high
vaccination coverage but it remains endemic in several other
countries, especially in tropical areas. Over the last 30 years,
several signiﬁcant changes have been observed in countries
with vaccination programmes. Firstly, toxigenic C. diphtheriae
infections have become very much less frequent, and many of
the cases observed are imported from endemic areas.
Secondly, autochtonous toxigenic infections are caused by
C. ulcerans, mostly transmitted by pets [1–3]. Furthermore, a
recent study demonstrated an asymptomatic carriage of 8% for
dogs in Osaka [4]. Contrasting with the decreased prevalence
of toxigenic C. diphtheriae, recent autochtonous cases have
been found to be associated with various non-toxigenic
C. diphtheriae isolates. In England and Wales, the number of
non-toxigenic isolates increased between 1986 (four isolates)
and 2006 (68 isolates), peaking at 294 isolates in 2000 (http://
www.hpa.org.uk/). Other countries with vaccination pro-
grammes have reported similar observations [5–10]. Clinical
features of the infections due to non-toxigenic isolates may be
indistinguishable from those due to toxigenic isolates, such as
cutaneous infections and pharyngitis. Moreover, they have
been associated with invasive infections such as bacteraemia,
endocarditis, and bone and joint infections [7, 11, 12].
Here, we report a description and analysis of the diversity
of non-toxigenic C. diphtheriae causing autochtonous infections
in mainland France.
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Materials and Methods
Clinical isolates
Non-toxigenicC. diphtheriae isolates of the collectionof the French
National reference centre (NRC) for Corynebacteria of the
diphtheriae complex were included in this study (n = 103). These
isolates, consecutively collected throughout mainland France
between 1977 and 2011, were either sent by clinical laboratories
for conﬁrmation of identiﬁcation and toxigenic assessment, or
provided by the Institut Pasteur Collection. Twenty-four of these
isolates have previously been characterized [7, 13].
Molecular identiﬁcation, phenotypic characterization and
antibiotic susceptibility
All isolates were identiﬁed using a speciﬁc PCR for the dtxR
gene [14]. Biotypes were determined using the API Coryne
strip test (product no. 20900; bioMerieux, Marcy l’Etoile,
France) and interpreted according to the World Health
Organisation guidelines [15]. Toxigenic status was assessed
using a PCR for the tox gene [16]. The sensitivities to 16
antibiotics were determined with a disc diffusion method
according to the French reference guidelines (CA-SFM) [17].
As there are no speciﬁc guidelines for Corynebacterium species,
the sensitivity was interpreted using the non-species-related
breakpoint of the CA-SFM. For isolates with decreased
sensitivity, the minimum inhibitory concentrations (MICs)
were evaluated by E-test (bioMerieux)
Multilocus sequence typing (MLST)
Multilocus sequence typing was performed as previously
described [18]. Sequence types (STs) were assigned by
comparing the sequences of each locus with similar sequences
deposited in the online PubMLST database (http://pubmlst.org/
cdiphtheriae/). New alleles and new STs were submitted to
this database.
A single isolate for each ST identiﬁed in this work, as well as
previously published STs, was included in this analysis [6, 8,
18]. Clonal analysis was performed using the eBurst program
(www.mlst.net). A clonal complex or eBurst group was
deﬁned as a cluster of isolates sharing six of seven alleles.
Phylogenetic analysis
Phylograms were constructed using the Jukes-Cantor algo-
rithm and the neighbour-joining method with the MEGA
program version 5 [19].
Sequencing of the dtxR gene
The dtxR gene was ampliﬁed and sequenced using the protocol
from Nakao et al. [20] and the TAQ PCR core kit (Qiagen,
Courtaboeuf, France). Amino-acid sequences were deduced from
nucleotide sequences using EMBOSS software (www.mobyle.
pasteur.fr) [21]. Both nucleotide and amino-acid sequences were
compared with those available in the GenBank database and new
sequences were submitted to the EMBL database.
Results
We investigated 103 isolates collected between 1977 and
2011. They were mainly isolated from respiratory (n = 42),
blood (n = 30) and cutaneous (n = 16) samples (Table 1).
Other sites included lymphatic node (n = 1), eye (n = 1), ear
(n = 1) and bone or joint (n = 5). For seven isolates, the origin
of the biological samples was not mentioned.
Microbiological characteristics
Corynebacterium diphtheriae mitis was the most common
biotype (n = 50; 48.5%) followed by belfanti (n = 37; 36.0%)
and gravis (n = 16; 15.5%). Belfanti isolates were mostly
collected from respiratory samples (31/37) and many mitis
isolates were from sterile sites, blood (25/50) and bone or
joint (4/50), and cutaneous (10/50) samples (Table 1). Gravis
and mitis isolates were obtained throughout the period,
whereas most belfanti isolates were from cases after 1996 (29
of 37 isolates). Similarly, 16% of isolates before 1995 and 52%
after this date were belfanti (Fig. 1). There was a peak of mitis
isolates, including almost all isolates collected from blood,
bone and joint, between 1990 and 1993.
Antimicrobial susceptibilities
Almost all isolates were susceptible to penicillin G (99%) and
erythromycin (98.1%). Lower sensitivity or resistance was
detected for 12 of 16 antibiotics tested. No isolate was
resistant to amoxicillin or other beta-lactams tested. The least
active antibiotics were tetracycline, rifampicin and ciproﬂox-
acin. All but one of the isolates with reduced sensitivity to
ciproﬂoxacin were biotype belfanti, isolated since the year
2000. Multiple resistance was rare and all the isolates resistant
to macrolides were susceptible to penicilin G. One isolate was
TABLE 1. Origin and biotype of non-toxigenic C. diphtheriae
Clinical samples
Biotypes
mitis Belfanti gravis
Cutaneous 10 1 5
Bone or joint 4 1 0
Respiratory 6 31 5
Blood 25 1 4
Others 1 1 1
Nc 4 2 1
Total 50 37 16
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intermediate to penicillin G (MIC, 2 lg/mL), cefotaxime (MIC,
2 lg/mL) and cotrimoxazole (MIC of cotrimoxazole, 3 lg/mL;
MIC of sulphamethoxazole, >1024 lg/mL and MIC of trimeth-
oprim, 8 mg/lL) and resistant to tetracycline (MIC, 32 lg/mL).
Isolates collected since 1997 had a decreased sensitivity to 10
antibiotics (Fig. 2).
Multilocus sequence typing
Multilocus sequence typing analysis allowed us to identify 63
STs, including the eight previously described among a series of
24 C. diphtheriae isolates causing invasive infections in France
(ST128, ST130, ST153, ST156, ST193, ST194, ST195 and
ST196) (14). Clonal analysis classiﬁed these French isolates
into six eBurst groups, three of which (eBurst groups 1, 3 and
11) were previously described by Bolt et al. [18]. ST5 and ST32
were clustered in the eBurst groups 11 and 1, respectively.
Almost all C. diphtheriae belfanti isolates (18 out of 25) are
part of eBurst group 3. The remaining belfanti isolates are
closely related to this eBurst group. Indeed, four belfanti isolates
(i.e. ST93, ST180, ST207 and ST215) are double locus variants
(DLV) of various isolates of eBurst group 3 and ST214 forms an
eBurst group 14with ST215 (Fig. 3; Table 2). The eBurst groups
12 and 13 and 14 are also each composed of two STs.
There was no linkage between ST or eBurst group and
clinical presentation or biotype, except for ST130 and eBurst
group 3: ST130 accounted for 23 of 24 isolates of the mitis
FIG. 1. Biotype distribution among C. diphtheriae isolated between 1977 and 2011. The biotypes of Corynebacterium diphtheriae isolates collected
between 1977 and 2011 by the French National Reference Centre (NRC) for Corynebacteria of the diphtheriae complex were determined as indicated
in Materials and methods.
FIG. 2. Antibiotic resistance of C. diphtheriae isolates before and after 1997. The antibiotic resistance of C. diphtheriae isolates collected between
1977 and 2011 by the French National Reference Centre (NRC) for Corynebacteria of the diphtheriae complex was determined as indicated in
Materials and methods.
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peak between 1990 and 1993 and most isolates were involved
in bacteraemia between 1991 and 1993; eBurst group 3 was
mostly associated with respiratory infections.
Phylogenetic analysis
Three distinct lineages were observed by phylogenetic analysis
(Fig. 4). Lineage I was composed of mitis and gravis isolates,
and all belfanti isolates were in lineages II and III. To assess the
degree of recombination within the bacterial population, the
index association (IA) was calculated for the overall population
and for each lineage [22]. The overall IA value was 0.348
(p <0.001); the IA values were 0.0841 (p 0.002) for lineage I
and 0.1113 (p <0.001) for lineage II, suggesting that C. diph-
theriae lineage I and II are in linkage disequilibrium and may be
considered as clonal.
dtxR gene analysis
Among the 63 representative sequence types, we identiﬁed 12
different nucleotide sequences of the dtxR gene, corresponding
to six different amino-acid sequences. One DtxR polypeptide
is encoded by six different nucleotide sequences whereas the
others are each encoded by a single nucleotide sequence.
Four protein sequences are identical to those of toxigenic
isolates, i.e. the reference strain PW8, isolate NCTC13129
and two clinical isolates from Romania (C. diphtheriae 9337 and
25298) [23–25]. The GeneBank database contains no sequence
identical to the remaining proteins (accession numbers
HE980017 and HE980018). Each protein sequence is har-
boured by a single isolate.
Discussion
The disappearance of autochthonous diphtheria due to
toxigenic C. diphtheriae in mainland France and in countries
FIG. 3. Minimum spanning tree of C. diphtheriae belfanti isolates from
France and other sequence types (STs) of eBurst group 3. Each circle
corresponds to a sequence type. The relationships between isolates
are indicated by the connections between them and numbers between
the circles indicate the number of allelic differences. Black lines
connecting pairs of STs are related to the number of alleles they differ
by: one or two alleles (thick lines), and three to seven alleles (dashed
lines). Grey zones between circles indicate that they belong to the
same clonal complex.
TABLE 2. Sequence type (ST) and eBurst group of non-
toxigenic C. diphtheriae
eBurst group ST Nb isolates Year of isolation
1 32 4 1984–2011
3 23 1 2000
3 42 3 1981–2002
3 81 2 2004–2008
3 92 1 2008
3 94 1 2008
3 106 2 2000–2009
3 107 1 2005
3 108 1 2007
3 144 1 1998
3 160 2 1992–2003
3 163 1 1992
3 167 2 1991–2007
3 168 2 1985–2004
3 169 1 2004
3 170 3 2004–2006
3 177 1 2006
3 178 1 2006
3 179 1 2004
3 208 1 2011
3 211 1 2001
3 216 1 2002
3 226 1 1985
11 5 1 2004
11 103 1 2006
12 223 1 1983
13 80 1 1983
13 128 3 1987–2003
14 214 1 2002
14 215 1 2002
86 1 2008
88 1 2008
89 1 2004
90 1 2007
93 1 2007
96 1 2008
98 1 2007
100 1 2006
130 23 1991–1993
132 1 1991
134 1 1999
135 1 1993
140 1 1999
153 2 1987–1991
156 3 1977–1990
180 1 2004
181 1 2005
182 1 2006
192 1 1983
193 1 1990
194 1 1990
195 1 2002
196 1 1990
206 1 2010
207 1 2010
213 1 2009
217 1 2002
222 1 1981
225 1 1984
227 1 1985
228 1 2011
229 1 2011
233 1 1986
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with high vaccination coverage is a direct consequence of the
large-scale use of diphtheria toxoid [1]. A switch in the
populations causing autochtonous infections from toxigenic to
non-toxigenic isolates in the 1990s and the 2000s has been
documented [5,6,26,27]. Here, we describe recent changes in
the French C. diphtheriae population, and draw conclusions
about the circulation of these bacteria.
Biotype
Corynebacterium diphtheriae belfanti isolates increased as a
proportion of the population during the study period. This
biotype seems to have a respiratory tropism whereas other
biotypes mostly cause cutaneous or invasive infections.
Interestingly, C. diphtheriae belfanti has rarely been reported
in the literature, and almost exclusively in vaccinated countries
(Canada, the United States and France) where there is
surveillance of such infections [18]. As most toxigenic isolates
are mitis and gravis, it is possible that the change of biotype is a
consequence of the disappearance of toxigenic isolates at the
end of the twentieth century. C. diphtheriae belfanti might have
an advantage over non-toxigenic mitis and gravis isolates for
colonizing or infecting the upper respiratory tract.
Antibiotic susceptibility
Most autochthonous French isolates are sensitive to ﬁrst-line
antibiotics prescribed for C. diphtheriae infection, conﬁrming
the validity of the current therapeutic guidelines [28–30].
However, we observed a trend among recent isolates for
diminished susceptibility to ten antibiotics, indicating that
antibiotic surveillance should be continued. Only one isolate
displayed cross-resistance to several classes of antibiotics
(penicillin G, cefotaxim, tetracycline and cotrimoxazol). Multi-
drug resistance seems to be rare among C. diphtheria; only one
such isolate has previously been described in Canada [31].
Almost 14% of our isolates displayed reduced sensitivity to
ciproﬂoxacin, and all were biotype belfanti collected in the
2000s. This apparent emerging resistance could be a conse-
quence of the use of antimicrobial agents, as described for
Streptococcus pneumoniae and the increased use of ﬂuoroqui-
nolones [32,33]. Similarly, the treatment of unrecognized
C. diphtheriae upper respiratory tract infections with ﬂuoroqu-
inolones, or the use of ﬂuoroquinolones in general, may be
having an effect on the C. diphtheriae bacterial population.
These possibilities are supported by the rare use of ciproﬂox-
acin for C. diphtheriae treatment and the observation of
decreased sensitivity only among recently collected isolates.
This in turn suggests that asymptomatic carriage of C. diphthe-
riae is not uncommon, but C. diphtheriae throat carriage has
been described to be rare or absent among patients with upper
respiratory tract infections [34] and asymptomatic individuals
[35]. However, these studies involved few socially/profession-
ally active and healthy subjects [35] and bacterial ﬂora of the
upper respiratory tract in infected patients may not be
representative of that in the general population [34]. Asymp-
tomatic throat carriage may also concern only a particular sub-
population or may be transient, and cutaneous carriage has not
been evaluated. In temperate countries, skin infections mostly
affect people with predisposing conditions and those who are
socio-economically disadvantaged [6,7].
Multilocus sequence Typing
Isolates from mainland France are distributed across a very
large number of STs. Most of them have only been found in
France and only seven (ST5, ST23, ST32, ST42, ST80, ST81 and
ST128) of 63 have previously been identiﬁed in another
country: Canada, the USA, Brazil, Poland, Russia and Kazakh-
stan [8,18]. However, the MLST technique was only recently
developed for C. diphtheriae typing and the number of isolates
analysed using this technique is still small. Furthermore, despite
the large number of STs identiﬁed, the isolates cluster in a
small number of eBurst groups. Other than eBurst group 14,
which has only been found on mainland France, all eBurst
groups recovered in this study are geographically dispersed,
and are represented in Western Europe (eBurst groups 1, 3,
11 and 13), Eastern Europe (eBurst groups 1 and 11), North
America (eBurst groups 1, 3 and 12) and South America
(eBurst group 13) [8,18]. Interestingly, the larger eBurst group
includes almost all C. diphtheriae belfanti isolates and is
exclusively located in North America and Western Europe,
geographical areas with high vaccination coverage and now
almost no autochthonous toxigenic isolates. Note that MLST
has mostly been applied to clinical isolates collected from
Eastern Europe, Western Europe and North America. This
may explain the geographical distribution of eBurst groups
described and especially the absence of eBurst group repre-
sentatives from Africa and Asia.
Phylogenic analysis
French C. diphtheriae isolates are distributed between three
distinct lineages. Two lineages (lineage I and II) have already
been described by Bolt et al. [18]. We demonstrate that
almost all of our C. diphtheriae belfanti isolates belong to a
single clonal complex and the IA suggests that they are clonal.
Lineage III is composed of a single isolate (ST 181) and is
phylogenetically distant from the two other lineages. It was
collected from a woman presenting with rhinitis. ST181 does
not share any allele with other French C. diphtheriae belfanti.
We compared the nucleotide sequences at each locus by
NCBI blast, and the rpoB sequence was homologous to that of
a C. diphtheriae belfanti isolate collected from the ear of a cat
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FIG. 4. Phylogenic representation using the neighbour-joining method corrected with the Jukes-Cantor algorithm for C. diphtheriae isolates. A
representative isolate of each sequence type (ST) recovered in mainland France was included. C. diphtheriae belfanti isolates are underlined. The
eBurst group identiﬁed by Bolt et al[18] and a new eBurst group are indicated: (▼) eBurst group 1, (●) eBurst group 3, (♦) eBurst group 11, (■)
eBurst group 12, (▲) eBurst group, (○) eBurst group 14.
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 980–987
CMI Farfour et al. Autochthonous non-toxigenic Corynebacterium diphtheriae isolation in France 985
[36]. The feline isolate carries the tox gene but does not
express the diphtheria toxin. Indeed, the nucleotide sequence
of the tox gene shows several substitutions and deletions,
which prematurely terminate the peptide at amino acid 25.
Furthermore, it has a higher sequence identity with the
C. ulcerans tox gene than the C. diphtheriae tox gene. Unfortu-
nately, the feline isolate was not characterized by MLST. It
would be of interest to determine the sequence type of feline
isolates to ﬁnd out if lineage III is composed of animal isolates
and if C. diphtheriae could be transmitted between humans and
animals.
dtxR
In toxigenic C. diphtheriae, the expression of the diphtheria
toxin is regulated by the diphtheria toxin repressor (DtxR)
[37,38]. This transcriptional regulator binds in an iron-depen-
dent way to operators of several genes, including those
involved in iron uptake and the tox gene. Under conditions of
low iron availability, as in the throat, DtxR does not repress
the tox gene, which consequently can be transcribed. Several
French non-toxigenic isolates harbour the same nucleotide or
amino-acid sequence of the dtxR gene and protein as toxigenic
isolates, suggesting that, if lysogenised by a beta-corynephage
harbouring the tox gene, they could produce the diphtheria
toxin.
Conclusion
We report evidence of recent changes in the C. diphtheriae
population of mainland France. It appears that toxigenic
C. diphtheriae mitis and gravis isolates were replaced at the
end of the twentieth century by non-toxigenic C. diphtheriae
mitis, gravis and above all belfanti biotypes. The belfanti
biotype seems to have a respiratory tropism and its population
structure is that of a large clonal complex distinct from other
biotypes. There is increasing resistance to several antibiotics,
including ciproﬂoxacin, suggestive of asymptomatic carriage or
unrecognized C. diphtheriae infections. Finally, sequencing of
the dtxR gene suggests that if lysogenised by a corynephage
harbouring the tox gene, several French autochthonous
isolates may express the diphtheria toxin.
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